# EQT life science: portfolio, investments and team

> EQT life science is a private equity based in Netherlands. 66 investments on record, latest Aug 2015. Portfolio, stages, co-investors and team.

Source: https://millionrounds.com/fund/lsp-bioventures (Millionrounds; every figure on the page links to its filing or article)

Netherlands · [Investor](https://millionrounds.com/investors)

# EQT life science

Filed with the SEC to raise a fund in Dec 2025, closing $1M. Last cheque observed Aug 2015.

Quiet New fund $580K, Dec 2025 Private equity Website unconfirmed Now at eqtgroup.com

Seed Series A Series B Medical Devices Connected Health In Vitro Diagnostics

Cheques on record

**0%** of best year **0** **cheques in 12 months**, 66 on record

Since the last cheque **4087** days **00** hrs **00** min **00** sec

Median round **$16M** Rounds led **0 of 66** Exits **17 from the portfolio** Mostly in **United States, 30%**

Pitch EQT life science

## EQT life science highlights

- 01 66 rounds on record
- 02 Mostly Series B and Series A: 56% of its rounds
- 03 17 exits from the portfolio

## What they do

- **Type:** Private equity (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Medical Devices Connected Health In Vitro Diagnostics
- **Based in:** Amsterdam, Netherlands
- **Cold pitches:** Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. [Tell us the right one](https://millionrounds.com/corrections?slug=lsp-bioventures).

## The record

Every round we can evidence, newest first **66 appearances**

- **2015** 3 rounds
- **Aug** **[Kuros Biosurgery](https://millionrounds.com/company/kuros-biosurgery)** Venture · CH **$15M** With 4 others
- **Jun** **[Neuravi](https://millionrounds.com/company/neuravi)** Series B · IE **$21M** With 3 others
- **Mar** **[Cardiac Dimensions](https://millionrounds.com/company/cardiac-dimensions)** Venture · US **$15M** With 4 others
- **2014** 8 rounds
- **Dec** **[Xeltis](https://millionrounds.com/company/xeltis)** Series B · CH **$34M** With 2 others
- **Nov** **[Curetis](https://millionrounds.com/company/curetis)** Series B · DE **$18M** With 6 others
- **Sept** **[Affimed Therapeutics](https://millionrounds.com/company/affimed-therapeutics)** Series E · DE **$16M** With 2 others
- **Jul** **[Mint Solutions](https://millionrounds.com/company/mint-solutions)** Series A · NL **$6.0M** With 1 other
- **Jul** **[Rotation Medical](https://millionrounds.com/company/rotation-medical)** Series B · US **$27M** With 2 others
- **Apr** **[Atlas Genetics](https://millionrounds.com/company/atlas-genetics)** Series B · GB **$28M** With 5 others
- **Apr** **[Sequana Medical](https://millionrounds.com/company/sequana-medical)** Series C · CH **$26M** With 5 others
- **Apr** **[Heart Metabolics](https://millionrounds.com/company/heart-metabolics)** Series A · US **$20M** With 4 others
- **2013** 2 rounds
- **Oct** **[Harvest Automation](https://millionrounds.com/company/harvest-automation)** Series C · US · bizjournals.com **$12M** With 4 others
- **Oct** **[Merus](https://millionrounds.com/company/merus)** Series B · NL · finsmes.com **$40M** With 4 others
- **2012** 7 rounds
- **Nov** **[Kiadis Pharma](https://millionrounds.com/company/kiadis-pharma)** Venture · NL · kiadis.com **$13M** With 4 others
- **Oct** **[Cobalt Technologies](https://millionrounds.com/company/cobalt-technologies)** Venture · US **$5.0M** With 2 others
- **Sept** **[IlluminOss Medical](https://millionrounds.com/company/illuminoss-medical)** Series C · US · marketwire.com **$28M** With 8 others
- **Apr** **[Cobalt Technologies](https://millionrounds.com/company/cobalt-technologies)** Venture · US **$2.9M** With 4 others
- **Jan** **[Prosensa](https://millionrounds.com/company/prosensa)** Venture · NL · reuters.com **$30M** With 6 others
- **Jan** **[Pronota](https://millionrounds.com/company/pronota)** Series C · BE · pronota.com **$4.8M** With 6 others
- **Jan** **[Probiodrug](https://millionrounds.com/company/probiodrug)** Venture · DE · finsmes.com **$19M** With 5 others
- **2011** 8 rounds
- **Dec** **[arGEN-X](https://millionrounds.com/company/argen-x)** Series B · NL · finsmes.com **$44M** With 7 others
- **Nov** **[Harvest Automation](https://millionrounds.com/company/harvest-automation)** Series B · US · fis.dowjones.com **$7.8M** With 3 others
- **Jul** **[Atlas Genetics](https://millionrounds.com/company/atlas-genetics)** Series B · GB · atlasgenetics.com **$27M** With 4 others
- **Jun** **[Mendor](https://millionrounds.com/company/mendor)** Series B · FI · classic.cnbc.com **$12M** With 3 others
- **Jun** **[Sapiens](https://millionrounds.com/company/sapiens)** Series A · DE · cisionwire.com **$19M** With 2 others
- **May** **[Cobalt Technologies](https://millionrounds.com/company/cobalt-technologies)** Series D · US · techcrunch.com **$20M** With 5 others
- **Feb** **[Activaero](https://millionrounds.com/company/activaero)** Series A · DE · cnbc.com **$6.8M** With 5 others
- **Jan** **[Nexstim](https://millionrounds.com/company/nexstim)** Venture · FI · tmcnet.com **$15M** With 5 others
- **2010** 8 rounds
- **Nov** **[Syntaxin](https://millionrounds.com/company/syntaxin)** Series C · GB · fiercebiotech.com **$29M** With 6 others
- **Mar** **[Seahorse Bioscience](https://millionrounds.com/company/seahorse-bioscience)** Series D · US · onbiovc.com **$5.0M** With 6 others
- **Feb** **[arGEN-X](https://millionrounds.com/company/argen-x)** Series A · NL · onbiovc.com **$4.5M** With 7 others
- **Feb** **[Promethera Biosciences](https://millionrounds.com/company/promethera-biosciences)** Series A · BE · onbiovc.com **$7.3M** With 2 others
- **Jan** **[Kreatech Diagnostics](https://millionrounds.com/company/kreatech-diagnostics)** Series B · NL · onbiovc.com **$2.7M** With 1 other
- **Jan** **[Merus](https://millionrounds.com/company/merus)** Series B · NL · merus.nl **$30M** With 3 others
- **Jan** **[Cellerix](https://millionrounds.com/company/cellerix)** Series C · ES · onbiovc.com **$38M** With 5 others
- **Jan** **[Harvest Automation](https://millionrounds.com/company/harvest-automation)** Series A · US · masshightech.com **$4.0M** With 1 other
- **2009** 8 rounds
- **Dec** **[Curetis](https://millionrounds.com/company/curetis)** Series A · DE · curetis.com **$28M** With 3 others
- **Nov** **[Kreatech Diagnostics](https://millionrounds.com/company/kreatech-diagnostics)** Venture · NL · kreatech.com **$3.0M** With 1 other
- **Nov** **[Cellerix](https://millionrounds.com/company/cellerix)** Series B · ES · cellerix.com **$41M** With 5 others
- **Nov** **[Trinity Biosystems](https://millionrounds.com/company/trinity-biosystems)** Debt · US · deals.venturebeat.com **$7.5M** With 4 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **14 named**

AP **Anne Portwich** Manager of the Manager i Filing they signed

CS **Christiaan Snyders** Manager of the AIFM i Filing they signed

FA **Fouad Azzam** Manager of the Manager i Filing they signed

JR **Joachim Rothe** Manager of the AIFM i Filing they signed

LA **LSP Advisory B.V.** AIFM i Filing they signed

MS **Magnus Sjocrona** Manager of the AIFM i Filing they signed

MW **Mark Wegter** Manager of the AIFM i Filing they signed

MK **Martijn Kleijwegt** Manager of the AIFM i Filing they signed

MK **Merijn Klaassen** Manager of the AIFM i Filing they signed

PB **Patrik Burnas** Manager of the AIFM i Filing they signed

PV **Peter Veldman** Manager of the AIFM i Filing they signed

RK **Rene Kuijten** Manager of the AIFM i Filing they signed

RD **Rudy Dekeyser** Manager of the Manager i Filing they signed

SH **Sara Huda** Manager of the AIFM i Filing they signed

We also hold **16** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## Exits from the portfolio

Companies it backed that were later bought or listed **17 in all**

**[Seahorse Bioscience](https://millionrounds.com/company/seahorse-bioscience)** Bought by [Agilent Technologies](https://millionrounds.com/fund/agilent-technologies) **$235M** Sept 2015

**[Hyperion Therapeutics](https://millionrounds.com/company/hyperion-therapeutics)** Bought by Horizon Pharma **$1.1B** Mar 2015

**[ActoGeniX](https://millionrounds.com/company/actogenix)** Bought by Intrexon Corporation **$60M** Feb 2015

**[Prosensa](https://millionrounds.com/company/prosensa)** Bought by BioMarin Pharmaceutical **$840M** Nov 2014

**[Sapiens](https://millionrounds.com/company/sapiens)** Bought by [Medtronic](https://millionrounds.com/fund/medtronic) **$200M** Aug 2014

**[Activaero](https://millionrounds.com/company/activaero)** Bought by [Vectura](https://millionrounds.com/fund/vectura) **Undisclosed** Mar 2014

**[Santarus](https://millionrounds.com/company/santarus)** Bought by [Salix Pharmaceuticals](https://millionrounds.com/fund/salix-pharmaceuticals) **$2.6B** Nov 2013

**[Syntaxin](https://millionrounds.com/company/syntaxin)** Bought by [Ipsen](https://millionrounds.com/fund/ipsen) **$206M** Jul 2013

**[Kreatech Diagnostics](https://millionrounds.com/company/kreatech-diagnostics)** Bought by Leica Biosystems St. Louis **Undisclosed** Jul 2013

**[Prosensa](https://millionrounds.com/company/prosensa)** Listed **$78M** Jun 2013

**[BMEYE](https://millionrounds.com/company/bmeye)** Bought by [Edwards Lifesciences](https://millionrounds.com/fund/edwards-lifesciences) **Undisclosed** Oct 2012

**[Pasteuria Bioscience](https://millionrounds.com/company/pasteuria-bioscience)** Bought by [Syngenta](https://millionrounds.com/fund/syngenta) **$113M** Sept 2012

**[Movetis](https://millionrounds.com/company/movetis)** Bought by [Shire](https://millionrounds.com/fund/shire) **$565M** Aug 2010

**[FlowCardia](https://millionrounds.com/company/flowcardia)** Bought by C. R. Bard **Undisclosed** May 2010

**[BioProcessors](https://millionrounds.com/company/bioprocessors)** Bought by Seahorse Bioscience **Undisclosed** Mar 2009

**[NewBiotics](https://millionrounds.com/company/newbiotics)** Bought by Celmed Biosciences **Undisclosed** Jul 2004

**[Santarus](https://millionrounds.com/company/santarus)** Listed **Undisclosed** Apr 2004

An exit counts when it came after the firm's first round in the company. From historical deal records.

New fund on file

**$580K**

raised in Dec 2025

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$16M** the round, not its cheque

Led 0 of 66 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Aug 2015
- **Exits:** 17 from the portfolio

Rounds by stage said on their site

- Series B said *22*
- Series A said *14*
- Venture *13*
- Series C *10*
- Series D *3*
- Series E *2*
- Seed said *-*

Cheques by year Led Joined

2001 2015

Often in the room with

- [Johnson & Johnson Development Corporation (JJDC)](https://millionrounds.com/fund/johnson-and-johnson-development-corporation) 8
- [Gimv](https://millionrounds.com/fund/gimv) 7
- [Novartis Venture Fund](https://millionrounds.com/fund/novartis-venture-fund) 7
- [KBC Private Equity](https://millionrounds.com/fund/kbc-private-equity) 5
- [SR One](https://millionrounds.com/fund/sr-one) 5
- [BB Biotech Ventures](https://millionrounds.com/fund/bb-biotech-ventures) 4

**Pitching EQT life science?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as EQT life science. A count of rooms they were both in, not a relationship either has claimed.

[**Johnson & Johnson Development Corporation (JJDC)** VC firm **8** rounds together](https://millionrounds.com/fund/johnson-and-johnson-development-corporation)[**Gimv** Private equity **7** rounds together](https://millionrounds.com/fund/gimv)[**Novartis Venture Fund** Corporate VC **7** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**KBC Private Equity** Private equity **5** rounds together](https://millionrounds.com/fund/kbc-private-equity)[**SR One** Corporate VC **5** rounds together](https://millionrounds.com/fund/sr-one)[**BB Biotech Ventures** Growth equity **4** rounds together](https://millionrounds.com/fund/bb-biotech-ventures)[**Pinnacle Ventures** VC firm **4** rounds together](https://millionrounds.com/fund/pinnacle-ventures)[**Quest for Growth** VC firm **4** rounds together](https://millionrounds.com/fund/quest-for-growth)[**Roche Venture Fund** Corporate VC **4** rounds together](https://millionrounds.com/fund/roche-venture-fund)[**VI Partners** VC firm **4** rounds together](https://millionrounds.com/fund/vi-partners)[**Ventech** VC firm **4** rounds together](https://millionrounds.com/fund/ventech)[**Abingworth** VC firm **3** rounds together](https://millionrounds.com/fund/abingworth)

## Quick answers about EQT life science

### What does EQT life science invest in?

EQT life science invests most often at Series B and Series A (56% of the rounds on record), in sectors such as Medical Devices, Connected Health and In Vitro Diagnostics.

### How active is EQT life science?

66 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2015.

### How big are EQT life science's cheques?

The median round it joins is $16M.

### Does EQT life science lead rounds?

Rarely, if at all: none of its 66 investments on record names it as the lead.

### Where does EQT life science invest?

Most of the companies it backs are in the United States (30%), the Netherlands (23%) and Germany (15%).

### Is EQT life science investing now?

No investments in the last 12 months; the latest was in Aug 2015.

### Who does EQT life science invest alongside?

Most often Johnson & Johnson Development Corporation (JJDC) (8 rounds together), Gimv (7 rounds together) and Novartis Venture Fund (7 rounds together).

### What kind of investor is EQT life science?

EQT life science is a private equity firm based in Amsterdam, Netherlands.

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=lsp-bioventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=lsp-bioventures)